Hap Trading, LLC Crinetics Pharmaceuticals, Inc. Transaction History
Hap Trading, LLC
- $1.06 Trillion
- Q2 2025
A detailed history of Hap Trading, LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Hap Trading, LLC holds 100,000 shares of CRNX stock, worth $4 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
100,000Holding current value
$4 Million% of portfolio
0.05%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CRNX
# of Institutions
240Shares Held
91.3MCall Options Held
59.7KPut Options Held
14.8K-
Vanguard Group Inc Valley Forge, PA9.17MShares$367 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.4MShares$256 Million1.78% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$249 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA5.81MShares$232 Million0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.59MShares$224 Million0.02% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $2.15B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...